Southern California Clinical and Translational Institute

南加州临床和转化研究所

• 批准号: 9929249
• 负责人: Thomas A Buchanan
• 金额: $ 53.47万
• 依托单位: UNIVERSITY OF SOUTHERN CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-07-01 至 2021-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9929249
• 关键词: Address; Adopted; Affect; Americas; California; Clinical; Clinical Research; Clinical Sciences; Communities; Community Health; County; Faculty; Fasting; Health; Health Services; Institutes; Interdisciplinary Study; Longevity; Los Angeles; Modeling; Pediatric Hospitals; Population Heterogeneity; Process; Rain; Research; Research Institute; Research Personnel; Research Priority; Science; Site; System; Training; Translational Research; Universities; Vision; base; care providers; community setting; design; digital; experience; health organization; improved; innovation; member; multidisciplinary; named group; novel strategies; peer; success

Contact PD/PI: Buchanan, Thomas A UL1 ABSTRACT   The Southern California Clinical and Translational Science Institute (SC CTSI) is a multidisciplinary research institute housed at the University of Southern California and Children's Hospital Los Angeles. In partnership with the Los Angeles County Department of Health Services and broad based community health organizations throughout Los Angeles, SC CTSI seeks to be a leader in engaging diverse communities and special populations in clinical and translational research to improve their health. SC CTSI It is led by a team of experienced faculty and staff members who have deep experience in developing and supporting clinical and translational research. They propose to address issues of health across the lifespan, as well as challenges in clinical and translational research, by pursuing five specific aims are: (1) Engage diverse communities and special populations, their care providers and our researchers to establish clinical research priorities; identify barriers to research participation; and develop, demonstrate and disseminate innovative approaches to assure fully partnered clinical research across diverse communities and the lifespan; (2) Promote team science in clinical research by assembling interdisciplinary teams, including community members, to collaboratively design and conduct clinical studies and develop innovative approaches to address challenges in clinical research; (3) Expand workforce capacity and capabilities by training researchers, staff, and clinical and community partners in team-based research in diverse and special populations; (4) Streamline clinical research processes and create efficient systems to support safe and effective conduct of high quality local and multicenter clinical research, in particular in diverse clinical and community settings; and (5) Participate as an exemplary CTSA hub, conduct multi-site network studies, adopt successful models from CTSA peers and develop and disseminate innovative strategies throughout the CTSA network. We also bring special strengths in engaging diverse communities, digital innovation, and regulatory science to develop new approaches to overcome challenges in clinical research. Success in achieving our aims will create new solutions for health problems affecting some of the fasting growing and most vulnerable special populations in America, define new approaches to research with diverse communities, and contribute our deep experience and expertise to the national CTSA network.   Project Summary/Abstract Page 73 Contact PD/PI: Buchanan, Thomas A UL1

联系PD/PI：Buchanan，托马斯A UL 1摘要   南加州临床和转化科学研究所（SC CTSI）是一个多学科研究机构， 研究所设在南加州大学和儿童医院洛杉矶。合作 与洛杉矶县卫生服务部和基础广泛的社区卫生组织合作， 在整个洛杉矶，SC CTSI致力于成为参与不同社区和特殊 临床和转化研究，以改善他们的健康。SC CTSI由以下团队领导： 经验丰富的教师和工作人员谁拥有丰富的经验，在开发和支持临床和 翻译研究他们建议解决整个生命周期的健康问题，以及 临床和转化研究，通过追求五个具体目标是：（1）参与不同的社区， 特殊人群，他们的护理提供者和我们的研究人员，以确定临床研究的优先事项;确定 研究参与的障碍;制定、展示和传播创新方法， 在不同的社区和生命周期中进行全面合作的临床研究;（2）促进团队科学， 临床研究，通过组装跨学科团队，包括社区成员， 设计和开展临床研究，并开发创新方法，以应对临床挑战 研究;（3）通过培训研究人员、工作人员和临床医生， 在不同和特殊人群中进行团队研究的社区合作伙伴;（4）简化临床 研究流程并创建有效的系统，以支持安全有效地进行高质量的本地和 多中心临床研究，特别是在不同的临床和社区环境;（5）作为一个 示范CTSA枢纽，进行多站点网络研究，采用CTSA同行的成功模式， 在整个CTSA网络中制定和传播创新战略。我们也带来了特殊的优势 参与不同的社区，数字创新和监管科学，以开发新的方法， 克服临床研究中的挑战。 成功实现我们的目标将为影响一些禁食的健康问题创造新的解决方案。 在美国不断增长和最脆弱的特殊人群，定义新的研究方法， 社区，并将我们的深厚经验和专业知识贡献给国家CTSA网络。   项目摘要/摘要第73页 联系PD/PI：Buchanan，托马斯A UL1